(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
1.43% $ 14.89
@ $13.37
Emitido: 14 feb 2024 @ 14:08
Retorno: 11.41%
Señal anterior: feb 13 - 10:35
Señal anterior:
Retorno: 0.00 %
Live Chart Being Loaded With Signals
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States...
Stats | |
---|---|
Volumen de hoy | 772 159 |
Volumen promedio | 1.34M |
Capitalización de mercado | 1.75B |
EPS | $0 ( 2024-03-20 ) |
Próxima fecha de ganancias | ( $0.340 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 23.63 |
ATR14 | $0.00800 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Tierney David S | Buy | 25 000 | Common stock, par value $0.001 per share |
2024-04-08 | Tierney David S | Sell | 25 000 | Common stock, par value $0.001 per share |
2024-04-08 | Tierney David S | Buy | 25 000 | Options to purchase common stock |
2024-03-27 | Elsbernd Brian | Sell | 25 000 | Common stock, par value $0.001 per share |
2024-02-15 | Del Carmen Jeffrey | Sell | 10 667 | Restricted Stock Units |
INSIDER POWER |
---|
37.04 |
Last 100 transactions |
Buy: 3 182 900 | Sell: 1 448 545 |
Volumen Correlación
Catalyst Pharmaceuticals Correlación
10 Correlaciones Más Positivas | |
---|---|
PMTS | 0.897 |
KPTI | 0.88 |
AVID | 0.873 |
PRAA | 0.854 |
FCCO | 0.852 |
BNIXU | 0.849 |
PINC | 0.848 |
KTCC | 0.844 |
PARA | 0.843 |
DTEA | 0.838 |
10 Correlaciones Más Negativas | |
---|---|
CVGI | -0.927 |
CRSP | -0.915 |
NNOX | -0.915 |
POWL | -0.914 |
ADMS | -0.914 |
FTDR | -0.912 |
MDXG | -0.912 |
FLGC | -0.905 |
CNCE | -0.905 |
RESN | -0.904 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Catalyst Pharmaceuticals Correlación - Moneda/Commodity
Catalyst Pharmaceuticals Finanzas
Annual | 2023 |
Ingresos: | $398.20M |
Beneficio Bruto: | $313.67M (78.77 %) |
EPS: | $0.670 |
FY | 2023 |
Ingresos: | $398.20M |
Beneficio Bruto: | $313.67M (78.77 %) |
EPS: | $0.670 |
FY | 2022 |
Ingresos: | $214.20M |
Beneficio Bruto: | $179.81M (83.94 %) |
EPS: | $0.800 |
FY | 2021 |
Ingresos: | $140.83M |
Beneficio Bruto: | $118.95M (84.46 %) |
EPS: | $0.380 |
Financial Reports:
No articles found.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico